Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third Dose of CoronaVac in Elderly at Different Intervals
NCT05398926Phase 4Completed
- Sponsor
- Sinovac Life Sciences
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Life Sciences. Started Dec 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05398926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398926.